9999999997-15-014579.txt : 20151113 9999999997-15-014579.hdr.sgml : 20151113 20151113144011 ACCESSION NUMBER: 9999999997-15-014579 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20151113 DATE AS OF CHANGE: 20151113 20151113 20151113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HedgePath Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001042418 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 541641133 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-13467 FILM NUMBER: 151228613 BUSINESS ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE STREET 2: SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 BUSINESS PHONE: (813) 864-2559 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE STREET 2: SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 19970714 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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